Charles River Acquires Vigene Biosciences This acquisition will provide clients access to a comprehensive cell and gene therapy solution, including CDMO capabilities for viral vectors and plasmid DNA. learn more Research Models & Services Discovery Services Safety Assessment Laboratory Sciences Biologics Testing Solutions QC Microbial Solutions Featured Story 2021 Novel FDA-Approved Drugs Today, we are a market leader and are proud to have worked on 86% of the novel FDA-approved drugs in 2021. Learn More CONVERSATIONS IN SCIENCE Innovation in Drug Discovery ABOUT US Our Capabilities Insights Featured Story Celebrating 2021 Learn More Vital Science S3, E02: Can MILs Strike a Killer Blow to Cancer? Learn More Featured Story Pfizer’s Implementation of a Rapid Sterility Method Learn More Media Coverage The Power of Collaboration: Using the Pandemic’s United Effort to Serve as a Model for Future Drug Development Learn More View All
Featured Story 2021 Novel FDA-Approved Drugs Today, we are a market leader and are proud to have worked on 86% of the novel FDA-approved drugs in 2021. Learn More
Media Coverage The Power of Collaboration: Using the Pandemic’s United Effort to Serve as a Model for Future Drug Development Learn More
The Alex and Jaci Hermstad Rare Disease Trailblazer Series - Her Stories: ALS Feb 08, 2022 | Virtual Learn More
2022 Society of Toxicology (SOT) Annual Meeting and ToxExpo Mar 27 - 31, 2022 | San Diego, CA Learn More
